Food Effect

2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Small Molecule
1100%
+ 1 programs with unclassified modality

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Jazz Pharmaceuticals
Jazz PharmaceuticalsCA - Palo Alto
1 program
1
SativexPhase 11 trial
Active Trials
NCT01322464Completed25Est. Feb 2008
H
HutchmedChina - Hong Kong
1 program
1
VolitinibPhase 1Small Molecule1 trial
Active Trials
NCT02017236Completed25Est. Jun 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
HutchmedVolitinib
Jazz PharmaceuticalsSativex

Clinical Trials (2)

Total enrollment: 50 patients across 2 trials

NCT02017236HutchmedVolitinib

A Food Effect Phase I Study of the Volitinib in Healthy Subjects

Start: Nov 2013Est. completion: Jun 201425 patients
Phase 1Completed
NCT01322464Jazz PharmaceuticalsSativex

Study to Assess Food Effect on Sativex Bioavailability

Start: Jan 2008Est. completion: Feb 200825 patients
Phase 1Completed

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

2 companies competing in this space